- Home
- CRBU vs RDCM Comparison
CRBU vs RDCM Comparison
Compare CRBU & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRBU | RDCM |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 205.7M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CRBU | RDCM |
|---|---|---|
| Price | $1.75 | $11.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $10.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.4M | 92.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.50 |
| Revenue Next Year | $5.37 | $9.74 |
| P/E Ratio | ★ N/A | $16.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $9.88 |
| 52 Week High | $3.53 | $15.14 |
Technical Indicators
Market Signals| Indicator | CRBU | RDCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 43.76 |
| Support Level | $1.71 | $10.77 |
| Resistance Level | $2.11 | $13.65 |
| Average True Range (ATR) | 0.15 | 0.68 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 36.00 | 39.16 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.